Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.86 USD | +2.76% | +7.75% | +162.41% |
25/06 | Dyne Therapeutics Insider Sold Shares Worth $1,401,902, According to a Recent SEC Filing | MT |
14/06 | Dyne Therapeutics Insider Sold Shares Worth $1,334,201, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+162.41% | 336.37Cr | |
+21.63% | 4.69TCr | |
+37.63% | 3.91TCr | |
-8.21% | 3.85TCr | |
+31.58% | 3.1TCr | |
-13.75% | 2.61TCr | |
+11.44% | 2.59TCr | |
+35.85% | 1.25TCr | |
-6.39% | 1.14TCr | |
-12.44% | 1.06TCr |
- Stock Market
- Equities
- DYN Stock
- News Dyne Therapeutics, Inc.
- Dyne Therapeutics Says European Medicines Agency Granted Orphan Drug Designation for DYNE-101